Skip to content
Main navigation
About
About the ACTG
ACTG Leadership, Committees and Centers
Underrepresented Populations
Contact Us
Sites & Trials
About the Clinical Trials Process
Our Clinical Trials and Sites
Slides of Study Results
Publications Page
Red Ribbon Registry
Community
Global Community Advisory Board
Community Voices
Community Resources
News
Press Releases & Announcements
Newsletters
For Researchers
Submit a proposal
Small Clinical Trials Advancing HIV Remission and Cure
Specimen Repository Website
Pubmed
HIV Databases
Member Login
English
Español
About
About the ACTG
ACTG Leadership, Committees and Centers
Underrepresented Populations
Contact Us
Sites & Trials
About the Clinical Trials Process
Our Clinical Trials and Sites
Slides of Study Results
Publications Page
Red Ribbon Registry
Community
Global Community Advisory Board
Community Voices
Community Resources
News
Press Releases & Announcements
Newsletters
For Researchers
Submit a proposal
Small Clinical Trials Advancing HIV Remission and Cure
Specimen Repository Website
Pubmed
HIV Databases
Member Login
English
Español
ACTG Announces Launch of ACTIV-2d, a Global Phase 3 Trial of the Novel Investigational COVID-19 Oral Antiviral Agent S‑217622
Aug 15, 2022
